STAT Plus: Pharmalittle: Trump claims on drug prices are mostly false; Merck to spin off old drugs into new company
Good morning, everyone, and welcome to the middle of the week, which arrived rather quickly, no? Well, congratulations are in order for getting this far, so please join us as we fire up the coffee kettle and celebrate with a cup of stimulation. We look for any excuse we can get, as you probably know. Meanwhile, we have assembled a few items of interest to go with that cup of stimulation. Hope your day is smashing and, as always, please do keep in touch. We appreciate cards, emails, and secret dossiers.
President Trump’s brief remarks on drug pricing during the State of the Union address appeared uncontroversial as he urged Congress to pass a bipartisan drug pricing bill, STAT says. Democrats, however, came armed with a surprisingly strong response: From the back of the House chamber, dozens of lawmakers stood, held up three fingers, and unleashed a three-syllable chant: “H.R. 3.” They were touting House Resolution 3, the aggressive bill Democrats passed in December that would allow Medicare to directly negotiate the price of up to 250 drugs.
Continue to STAT Plus to read the full story…
